These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

87 related articles for article (PubMed ID: 15028387)

  • 1. A randomized trial of aspirin on the risk of embolic events in patients with infective endocarditis.
    Connolly DL; Choudhury A; Davis RC; Lip GY
    J Am Coll Cardiol; 2004 Mar; 43(6):1134-5; author reply 1135. PubMed ID: 15028387
    [No Abstract]   [Full Text] [Related]  

  • 2. Effect of long-term aspirin use on embolic events in infective endocarditis.
    Chan KL; Tam J; Dumesnil JG; Cujec B; Sanfilippo AJ; Jue J; Turek M; Robinson T; Williams K
    Clin Infect Dis; 2008 Jan; 46(1):37-41. PubMed ID: 18171211
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A randomized trial of aspirin on the risk of embolic events in patients with infective endocarditis.
    Chan KL; Dumesnil JG; Cujec B; Sanfilippo AJ; Jue J; Turek MA; Robinson TI; Moher D;
    J Am Coll Cardiol; 2003 Sep; 42(5):775-80. PubMed ID: 12957419
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comments in response to "Analysis of risk of bleeding complications after different doses of aspirin in 192,036 patients enrolled in 31 randomized controlled trials".
    Fisher M; Knappertz V
    Am J Cardiol; 2005 Nov; 96(10):1467. PubMed ID: 16275203
    [No Abstract]   [Full Text] [Related]  

  • 5. Analysis of risk of bleeding complications after different doses of aspirin in 192,036 patients enrolled in 31 randomized controlled trials.
    Serebruany VL; Steinhubl SR; Berger PB; Malinin AI; Baggish JS; Bhatt DL; Topol EJ
    Am J Cardiol; 2005 May; 95(10):1218-22. PubMed ID: 15877994
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Impact of prior antiplatelet therapy on risk of embolism in infective endocarditis.
    Anavekar NS; Tleyjeh IM; Anavekar NS; Mirzoyev Z; Steckelberg JM; Haddad C; Khandaker MH; Wilson WR; Chandrasekaran K; Baddour LM
    Clin Infect Dis; 2007 May; 44(9):1180-6. PubMed ID: 17407036
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [First WARFASA, now ASPIRE. The new career of ASS in long-term thromboembolism prevention].
    Einecke D
    MMW Fortschr Med; 2012 Nov; 154(20):18. PubMed ID: 23234110
    [No Abstract]   [Full Text] [Related]  

  • 8. [Anticoagulation therapy in patients with infectious endocarditis: a therapeutic dilemma].
    Thompson J; Loeliger EA
    Ned Tijdschr Geneeskd; 1984 Oct; 128(42):1998-2000. PubMed ID: 6504190
    [No Abstract]   [Full Text] [Related]  

  • 9. Prasugrel: new drug. After angioplasty and stenting: continue to use aspirin + clopidogrel.
    Prescrire Int; 2009 Oct; 18(103):193-5. PubMed ID: 19877380
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Aspirin combined with clopidogrel (Plavix) decreases cardiovascular events in patients with acute coronary syndrome.
    Walker CW; Dawley CA; Fletcher SF
    Am Fam Physician; 2007 Dec; 76(11):1643-5. PubMed ID: 18092705
    [No Abstract]   [Full Text] [Related]  

  • 11. Secondary stroke prevention set to benefit from PRoFESS trial: extended-release dipyridamole plus aspirin (Asasantin Retard) and clopidogrel share very similar benefit-risk ratio in vascular prevention.
    Cardiovasc J Afr; 2008; 19(3):165. PubMed ID: 18568182
    [No Abstract]   [Full Text] [Related]  

  • 12. Bleeding while starting anticoagulation for thromboembolism prophylaxis in elderly patients with atrial fibrillation: from bad to worse.
    Wyse DG
    Circulation; 2007 May; 115(21):2684-6. PubMed ID: 17533193
    [No Abstract]   [Full Text] [Related]  

  • 13. Combination antithrombotic therapy with antiplatelet agents and anticoagulants for patients with atherosclerotic heart disease.
    Arjomand H; Cohen M; Ezekowitz MD
    J Invasive Cardiol; 2004 May; 16(5):271-8. PubMed ID: 15152137
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Adding aspirin to clopidogrel after TIA and ischemic stroke: benefits do not match risks.
    Hankey GJ; Eikelboom JW
    Neurology; 2005 Apr; 64(7):1117-21. PubMed ID: 15824331
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Clopidogrel as basic therapy in high-risk stroke patients].
    Mattle HP
    Praxis (Bern 1994); 2004 Aug; 93(34):1364. PubMed ID: 15468694
    [No Abstract]   [Full Text] [Related]  

  • 16. MATCH results: implications for the internist.
    Lutsep HL
    Am J Med; 2006 Jun; 119(6):526.e1-7. PubMed ID: 16750967
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Aspirin, clopidogrel, and warfarin: is the combination appropriate and effective or inappropriate and too dangerous?
    Hermosillo AJ; Spinler SA
    Ann Pharmacother; 2008 Jun; 42(6):790-805. PubMed ID: 18477734
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Aspirin to prevent heart attack and stroke: what's the right dose?
    Dalen JE
    Am J Med; 2006 Mar; 119(3):198-202. PubMed ID: 16490462
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Massive hemorrhage into the paranephric cellular tissue as a consequence of a thromboembolism of the superior branch of the renal artery].
    Aĭvazian AV
    Urol Nefrol (Mosk); 1978; (6):62-3. PubMed ID: 715959
    [No Abstract]   [Full Text] [Related]  

  • 20. Risks and benefits of combining aspirin with anticoagulant therapy in patients with atrial fibrillation: an exploratory analysis of stroke prevention using an oral thrombin inhibitor in atrial fibrillation (SPORTIF) trials.
    Flaker GC; Gruber M; Connolly SJ; Goldman S; Chaparro S; Vahanian A; Halinen MO; Horrow J; Halperin JL;
    Am Heart J; 2006 Nov; 152(5):967-73. PubMed ID: 17070169
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.